受强制性开放获取政策约束的文章 - Ahmed Elwakeel了解详情
可在其他位置公开访问的文章：6 篇
Marine carotenoid fucoxanthin possesses anti-metastasis activity: Molecular evidence
S Garg, S Afzal, A Elwakeel, D Sharma, N Radhakrishnan, JK Dhanjal, ...
Marine drugs 17 (6), 338, 2019
强制性开放获取政策： Department of Biotechnology, India
Soyasapogenol-A targets CARF and results in suppression of tumor growth and metastasis in p53 compromised cancer cells
A Omar, RS Kalra, J Putri, A Elwakeel, SC Kaul, R Wadhwa
Scientific reports 10 (1), 6323, 2020
强制性开放获取政策： Department of Biotechnology, India
Identification and Characterization of MortaparibPlus—A Novel Triazole Derivative That Targets Mortalin-p53 Interaction and Inhibits Cancer-Cell Proliferation by …
AN Sari, A Elwakeel, JK Dhanjal, V Kumar, D Sundar, SC Kaul, ...
Cancers 13 (4), 835, 2021
强制性开放获取政策： Department of Biotechnology, India
Abrogating the interaction between p53 and mortalin (Grp75/HSPA9/mtHsp70) for cancer therapy: the story so far
A Elwakeel
Frontiers in Cell and Developmental Biology 10, 879632, 2022
强制性开放获取政策： Japan Science and Technology Agency
A low dose combination of withaferin A and caffeic acid phenethyl ester possesses anti-metastatic potential in vitro: molecular targets and mechanisms
AN Sari, JK Dhanjal, A Elwakeel, V Kumar, HN Meidinna, H Zhang, ...
Cancers 14 (3), 787, 2022
强制性开放获取政策： Department of Biotechnology, India
Mutant p53L194F Harboring Luminal-A Breast Cancer Cells Are Refractory to Apoptosis and Cell Cycle Arrest in Response to MortaparibPlus, a Multimodal Small …
A Elwakeel, AN Sari, JK Dhanjal, HN Meidinna, D Sundar, SC Kaul, ...
Cancers 13 (12), 3043, 2021
强制性开放获取政策： Department of Biotechnology, India
出版信息和资助信息由计算机程序自动确定